Wall Street Analysts Predict a 25.1% Upside in Teva Pharmaceutical Industries (TEVA): Here's What You Should Know

Shares of Teva Pharmaceutical Industries Ltd. (TEVA) have gained 2.9% over the past four weeks to close the last trading session at $18.25, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of$22.83 indicates a potential upside of 25.1%.The average comprises six short-term price targets ranging from a low of $18 to a high of$26, with a standard deviation of $2.79. While the lowest ...